The Effects of Different Formulations of Oral Contraceptive Agents on Lipid and Carbohydrate Metabolism
Open Access
- 15 November 1990
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 323 (20), 1375-1381
- https://doi.org/10.1056/nejm199011153232003
Abstract
Oral contraceptives can induce changes in lipid and carbohydrate metabolism similar to those associated with an increased risk of coronary heart disease, including increased serum triglyceride, low-density lipoprotein (LDL) cholesterol, and insulin levels and decreased high-density lipoprotein (HDL) cholesterol levels. In this study, we examined whether modification of the type or dose of progestin in oral-contraceptive preparations diminishes these changes.Keywords
This publication has 37 references indexed in Scilit:
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989
- ContraceptionNew England Journal of Medicine, 1989
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questionsAmerican Heart Journal, 1987
- Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham StudyAmerican Heart Journal, 1987
- Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein CholesterolNew England Journal of Medicine, 1983
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- COMPARISON OF EFFECTS OF DIFFERENT COMBINED ORAL-CONTRACEPTIVE FORMULATIONS ON CARBOHYDRATE AND LIPID METABOLISMThe Lancet, 1979
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogenJournal of Clinical Pathology, 1969